GLOBUS MEDICAL INC - A

GMED is the ticker for Globus Medical, a medical device company that designs, develops, and markets implants, instruments, and systems for spine surgery and other musculoskeletal procedures. Its portfolio includes fusion products, motion-preserving technologies, and robotic-assisted surgery platforms. The company sells primarily to hospitals and surgeons, generating revenue through procedural sales and capital equipment placements.

The current price of GMED stock changes throughout each trading day based on market supply and demand. To see the latest quote, including pre-market or after-hours movement, check the live price displayed at the top of this GMED stock detail page. That section typically shows the most recent trade, daily change, and timestamp for the data.

Whether GMED looks overvalued or undervalued depends on the valuation metrics you compare, such as price-to-earnings, price-to-sales, or enterprise value relative to EBITDA, and how those multiples stack up against peers and GMED's own history. Because these figures change with the share price, review the current valuation data shown on this page rather than relying on a static judgment.

GMED can trade in pre-market and after-hours sessions on U.S. exchanges, though volume is often lower and spreads may be wider than during regular hours. Extended-hours trading generally requires a broker that supports it and may involve additional risks, such as limited liquidity and greater price volatility. Check your brokerage's specific rules and available session times for GMED.

Analyzing GMED's financial performance typically involves reviewing its quarterly and annual reports, focusing on revenue growth, gross margin, operating margin, net income, and cash flow from operations. Investors often compare these figures year over year and against competitors in the medical device sector. Earnings releases and SEC filings provide the underlying data for this analysis.

Risks for GMED include regulatory and reimbursement changes affecting spine and orthopedic procedures, product liability or recall exposure, competition from larger medical device companies, and reliance on new product adoption such as surgical robotics. Macro factors like hospital capital spending cycles and supply chain disruptions can also influence results. These risks can affect revenue, margins, and the stock price.